- Filed
- Nov 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 10, 2025 | 5.89M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 4.48M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 4.28M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 4.04M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 3.68M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $1.16M |
| Capex | Q3 2025 · Sep 30, 2024 | $1.13M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$2.56M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$515K |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $13.44M |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $15.19M |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $1.88M |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $0 |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $7.08M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $7.26M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2024 | $7.06M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $1.31M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $532K |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $2.98M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $4.97M |
| Stockholders Equity restated | Q3 2025 · Sep 30, 2024 | $9.4M |
| Stockholders Equity restated | Q3 2025 · Jun 30, 2024 | $9.51M |
| Stockholders Equity restated | Q3 2025 · Mar 31, 2024 | $9.43M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $12.69M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $15.03M |
| Current Liabilities | Q3 2025 · Jun 30, 2025 | $12.55M |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $13.6M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $13.4M |
| Current Liabilities restated | Q3 2025 · Sep 30, 2024 | $13.17M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $11.3M |
| Current Liabilities | Q3 2025 · Mar 31, 2024 | $11.76M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $29.4M |
| Total Liabilities | Q3 2025 · Jun 30, 2025 | $28.96M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $30.05M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $29.96M |
| Total Liabilities restated | Q3 2025 · Sep 30, 2024 | $29.98M |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $29.25M |
| Total Liabilities | Q3 2025 · Mar 31, 2024 | $29.79M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $14.27M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $16.6M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $30.72M |
| Total Assets | Q3 2025 · Jun 30, 2025 | $29.49M |
| Total Assets | Q3 2025 · Mar 31, 2025 | $33.03M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $34.93M |
| Total Assets restated | Q3 2025 · Sep 30, 2024 | $39.38M |
| Total Assets | Q3 2025 · Jun 30, 2024 | $38.76M |
| Total Assets | Q3 2025 · Mar 31, 2024 | $39.23M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.36 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$1.48 |
| Eps Diluted | Q3 2025 · Jun 30, 2025 | −$0.62 |
| Eps Diluted | Q3 2025 · Jun 30, 2025 | −$1.13 |
| Eps Diluted | Q3 2025 · Mar 31, 2025 | −$0.51 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$0.51 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$1.50 |
| Eps Diluted | Q3 2025 · Jun 30, 2024 | −$0.03 |
| Eps Diluted | Q3 2025 · Jun 30, 2024 | −$0.99 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$0.10 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.36 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$1.48 |
| Eps Basic | Q3 2025 · Jun 30, 2025 | −$0.62 |
| Eps Basic | Q3 2025 · Jun 30, 2025 | −$1.13 |
| Eps Basic | Q3 2025 · Mar 31, 2025 | −$0.51 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$0.51 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$1.50 |
| Eps Basic | Q3 2025 · Jun 30, 2024 | −$0.03 |
| Eps Basic | Q3 2025 · Jun 30, 2024 | −$0.99 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | −$0.10 |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $172K |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $354K |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $243K |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $683K |
| Net Income | Q3 2025 · Sep 30, 2025 | −$1.62M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$6.32M |
| Net Income | Q3 2025 · Jun 30, 2025 | −$2.58M |
| Net Income | Q3 2025 · Jun 30, 2025 | −$4.7M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$2.12M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$2.07M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$5.53M |
| Net Income restated | Q3 2025 · Jun 30, 2024 | −$91K |
| Net Income | Q3 2025 · Jun 30, 2024 | −$3.46M |
| Net Income restated | Q3 2025 · Mar 31, 2024 | −$3.37M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$1.17M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$5.19M |
| Operating Income | Q3 2025 · Jun 30, 2025 | −$2.31M |
| Operating Income | Q3 2025 · Jun 30, 2025 | −$4.02M |
| Operating Income | Q3 2025 · Mar 31, 2025 | −$1.71M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$1.61M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$4.97M |
| Operating Income | Q3 2025 · Jun 30, 2024 | −$478K |
| Operating Income | Q3 2025 · Jun 30, 2024 | −$3.37M |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$2.89M |
| Gross Profit | Q3 2025 · Sep 30, 2025 | $4.18M |
| Gross Profit | Q3 2025 · Sep 30, 2025 | $12.27M |
| Gross Profit restated | Q3 2025 · Sep 30, 2024 | $5.29M |
| Gross Profit restated | Q3 2025 · Sep 30, 2024 | $13.46M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $2.75M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $9.14M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $3.51M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $10.53M |
| Revenue | Q3 2025 · Sep 30, 2025 | $6.93M |
| Revenue | Q3 2025 · Sep 30, 2025 | $21.4M |
| Revenue | Q3 2025 · Sep 30, 2024 | $8.8M |
| Revenue | Q3 2025 · Sep 30, 2024 | $23.99M |